PharmaCorp Rx (TSXV:PCRX) Other Long-Term Liabilities: C$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
37 GF Score
Price C$0.47
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Other Long-Term Liabilities?

PharmaCorp Rx TSXV:PCRX 37 Other Long-Term Liabilities is C$0.00 Mil as of Jun. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

PharmaCorp Rx's other long-term liabilities for the quarter that ended in Jun. 2026 was C$0.00 Mil.

PharmaCorp Rx's quarterly other long-term liabilities increased from Dec. 2025 (C$-0.00 Mil) to Mar. 2026 (C$-0.00 Mil) and increased from Mar. 2026 (C$-0.00 Mil) to Jun. 2026 (C$0.00 Mil).

PharmaCorp Rx's annual other long-term liabilities stayed the same from Dec. 2023 (C$0.00 Mil) to Dec. 2024 (C$0.00 Mil) but then declined from Dec. 2024 (C$0.00 Mil) to Dec. 2025 (C$-0.00 Mil).

PharmaCorp Rx Other Long-Term Liabilities Related Terms

PharmaCorp Rx Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Other Long-Term Liabilities Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
0.00 0.00 0.00 0.00 -0.00

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.00 0.00
TSXV:PCRX
37GF Score
PharmaCorp Rx Inc TSXV:PCRX
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of C$0.00 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Other Long-Term Liabilities of C$0.00 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Other Long-Term Liabilities too high?
PharmaCorp Rx's current Other Long-Term Liabilities is C$0.00 Mil. Overall, PharmaCorp Rx has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Other Long-Term Liabilities compare to competitors?
PharmaCorp Rx's Other Long-Term Liabilities of C$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PharmaCorp Rx and its competitors. PharmaCorp Rx's current Other Long-Term Liabilities is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Other Long-Term Liabilities of C$0.00 Mil. The current Other Long-Term Liabilities is C$0.00 Mil. PharmaCorp Rx's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Other Long-Term Liabilities is C$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
37GF Score

Get the complete analysis for TSXV:PCRX

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.47
Price